Literature DB >> 18632669

Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex.

Liang-Nian Song1, Edward P Gelmann.   

Abstract

beta-Catenin is a multifunctional mediator of cellular signaling and an oncogene. Nuclear beta-catenin, when complexed with members of the T-cell factor (TCF)/leukocyte enhancer factor family of DNA-binding proteins, mediates transcriptional activation important for embryonic development and adult cell homeostasis. Deregulation of intracellular levels of beta-catenin is an early event in the development of a variety of cancers. We observed that the proteins silencing mediator for retinoid and thyroid hormone receptor (SMRT) and the nuclear receptor corepressor (NCoR) are negative regulators of transcription induced by the beta-catenin-TCF4 complex. Overexpression of SMRT and NCoR attenuated the transcription of beta-catenin-TCF4-specific reporter gene and of CCND1, an endogenous beta-catenin target gene. Knockdown of endogenous SMRT or NCoR by short interfering RNA augmented the beta-catenin-TCF4-mediated reporter gene expression. Glutathione S-transferase pulldown experiments showed there was a direct physical association of SMRT and NCoR with both beta-catenin and TCF4. DNA-protein interaction studies revealed that the interactions between either SMRT or NCoR and beta-catenin or TCF4 occurred at the promoter regions of CCND1 and other target genes. These findings demonstrate an important role for corepressors SMRT and NCoR in the regulation of beta-catenin-TCF4-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632669      PMCID: PMC2533793          DOI: 10.1074/jbc.M800325200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro.

Authors:  A Hecht; C M Litterst; O Huber; R Kemler
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

Review 2.  Linking colorectal cancer to Wnt signaling.

Authors:  M Bienz; H Clevers
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.

Authors:  Dongqing Wang; S Stoney Simons
Journal:  Mol Endocrinol       Date:  2005-03-17

Review 4.  Wnt signaling in disease and in development.

Authors:  Roel Nusse
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

Review 5.  Wnt signalling in stem cells and cancer.

Authors:  Tannishtha Reya; Hans Clevers
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Pygopus and legless provide essential transcriptional coactivator functions to armadillo/beta-catenin.

Authors:  Raymond Hoffmans; Reto Städeli; Konrad Basler
Journal:  Curr Biol       Date:  2005-07-12       Impact factor: 10.834

7.  Functional interaction between beta-catenin and FOXO in oxidative stress signaling.

Authors:  Marieke A G Essers; Lydia M M de Vries-Smits; Nick Barker; Paulien E Polderman; Boudewijn M T Burgering; Hendrik C Korswagen
Journal:  Science       Date:  2005-05-20       Impact factor: 47.728

8.  Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.

Authors:  Hong Ma; Cu Nguyen; Kyung-Soon Lee; Michael Kahn
Journal:  Oncogene       Date:  2005-05-19       Impact factor: 9.867

9.  Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases.

Authors:  M Saleh; I Rambaldi; X J Yang; M S Featherstone
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

10.  The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.

Authors:  Myles C Hodgson; Inna Astapova; Shinta Cheng; Larissa J Lee; Manon C Verhoeven; Eunis Choi; Steven P Balk; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2004-12-14       Impact factor: 5.157

View more
  9 in total

1.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

2.  A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.

Authors:  Filemon Dela Cruz; Melissa Terry; Igor Matushansky
Journal:  Differentiation       Date:  2012-03-08       Impact factor: 3.880

Review 3.  The many faces and functions of β-catenin.

Authors:  Tomas Valenta; George Hausmann; Konrad Basler
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

4.  Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization.

Authors:  Etay Ziv; Hooman Yarmohammadi; F Edward Boas; Elena Nadia Petre; Karen T Brown; Stephen B Solomon; David Solit; Diane Reidy; Joseph P Erinjeri
Journal:  J Vasc Interv Radiol       Date:  2017-01-24       Impact factor: 3.464

5.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

Review 6.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

7.  FMRP recruitment of β-catenin to the translation pre-initiation complex represses translation.

Authors:  Saviz Ehyai; Tetsuaki Miyake; Declan Williams; Jyotsna Vinayak; Mark A Bayfield; John C McDermott
Journal:  EMBO Rep       Date:  2018-10-25       Impact factor: 8.807

8.  Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.

Authors:  Marcy E Beildeck; Md Islam; Salimuddin Shah; Joellen Welsh; Stephen W Byers
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

9.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.

Authors: 
Journal:  Cell       Date:  2017-06-15       Impact factor: 66.850

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.